Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye Journal Article
| Authors: | Plimack, E. R.; Hoffman-Censits, J.; Rosenberg, J. E.; Wong, Y. N.; Bellmunt, J.; Choueiri, T. K. |
| Article Title: | Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye |
| Keywords: | cancer survival; drug tolerability; cisplatin; doxorubicin; cancer combination chemotherapy; drug efficacy; drug safety; gemcitabine; cancer adjuvant therapy; cancer patient; disease free survival; methotrexate; nuclear magnetic resonance imaging; outcome assessment; letter; dna repair; multiple cycle treatment; gene expression; vinblastine; drug dose regimen; clinical trial (topic); muscle invasive bladder cancer; human |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 36 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-12-20 |
| Start Page: | 4171 |
| End Page: | 4172 |
| Language: | English |
| DOI: | 10.1200/jco.2014.58.5281 |
| PROVIDER: | scopus |
| PUBMED: | 25385730 |
| DOI/URL: | |
| Notes: | Export Date: 2 February 2015 -- Source: Scopus |
